연구동향 분석

Development and validation of LC-MS/MS for bioanalysis of hydroxychloroquine in human whole blood

박정열 주성수 권영이 김서진 장수길 송현호 2018년

논문상세정보
인용/피인용

' Development and validation of LC-MS/MS for bioanalysis of hydroxychloroquine in human whole blood' 의 참고문헌

  • Very low blood hydroxychloroquine concentration as an objective marker of poor adherence to treatment of systemic lupus erythematosus
  • Therapy for Lyme arthritis: strategies for the treatment of antibiotic-refractory arthritis
    Steere AC [2006]
  • The roles of stereochemistry and partial areas in a parallel design study to assess the bioequivalence of two formulations of hydroxychloroquine: a drug with a very long half-life
    Midha KK [1996]
  • The efficacy of antimalarials in systemic lupus erythematosus
    Nayak V [1996]
  • Simple and specific reversed-phase liquid chromatographic method with diode-array detection for simultaneous determination of serum hydroxychloroquine, chloroquine and some corticosteroids
    Volin P [1995]
  • Population pharmacokinetics of hydroxychloroquine in patients with rheumatoid arthritis
  • Plasma protein binding of the enantiomers of hydroxychloroquine and metabolites
  • Plasma hydroxychloroquine concentrations and efficacy in rheumatoid arthritis
    Miller DR [1987]
  • Pharmacokinetics of hydroxychloroquine and its clinical implications in chemoprophylaxis against malaria caused by Plasmodium vivax
    Lim HS [2009]
  • Method development and validation for rapid quantification of hydroxychloroquine in human blood using liquid chromatography-tandem mass spectrometry
    Wang LZ [2012]
  • Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus
  • Hyroxychloroquine sulfate in rheumatoid arthritis: long-term response rate and predictive parameter
    Bell CL [1983]
  • Hydroxychloroquine concentration-response relationships in patients with rheumatoid arthritis
    Munster T [2002]
  • High-performance liquid chromatographic assay for hydroxychloroquine and three of its major metabolites, desethylhydroxychloroquine, desethylchloroquine and bidesethylchloroquine, in human plasma
    Brown RR [1986]
  • High performance liquid chromatographic assay for hydroxychloroquine and metabolites in blood and plasma, using a stationary phase of poly (styrenedivinylbenzene) and a mobile phase at pH 11, with fluorimetric detection
    Tett SE [1985]
  • Estimation of plasma hydroxychloroquine by high-performance liquid chromatography with ultraviolet detection
    Morris RG [1985]
  • Enantioselective disposition of hydroxychloroquine after a single oral dose of the racemate to healthy subjects
    Ducharme J [1995]
  • Drug information handbook with international trade names index
    Lacy CF [2010]
  • Disposition and absorption of hydroxychloroquine enantiomers following a single dose of the racemate
  • Chronic ulcerative stomatitis (CUS). Lichen planus disseminatus, unguium pedis utriusque and pseudopelade
  • Bioavailability of hydroxychloroquine tablets in healthy volunteers
    Tett SE [1989]
  • Antimalarials in rheumatic diseases
    Tett S [1990]
  • Animal toxicity and pharmacokinetics of hydroxychloroquine sulphate
  • A dose-ranging study of the pharmacokinetics of hydroxychloroquine following intravenous administration to healthy volunteers
    Tett SE [1988]